ANTG’S THC-DOMINANT CANNABIS FLOWERS NOW LISTED ON THE ARTG FOR EXPORT
ANTG has now listed two new THC-dominant medicinal cannabis strains on the Australian Register of Therapeutic Goods (ARTG). Listing on the ARTG allows our products to be lawfully exported from Australia to overseas patients. We are very proud to have achieved this milestone and diversified the cannabinoid-based medical treatments ANTG can offer patients to meet their individual needs. Our dried THC cannabis flowers are due to be exported to the European Union.
In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.
We’re thrilled to announce we have received our export licence from the Drug Control Section of the ODC (Office of Drug Control). We’re firmly on course to continue to lead the way and be the first medicinal cannabis company in Australia to export cannabis flower to the EU since export was legalised in 2018.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.LEARN ABOUT ANTG HERE >